Patents Represented by Attorney Janice E. Williams
  • Patent number: 5006535
    Abstract: Substituted 4-aminoquinazoline derivatives which are inhibitors of gastric acid secretion. A compound of the invention is ethyl 8-methoxy-4-(4-methyl-3-thienyl-amino)quinoline-3-carboxylate.
    Type: Grant
    Filed: February 23, 1989
    Date of Patent: April 9, 1991
    Assignee: Smith Kline & French Laboratories Ltd.
    Inventors: Robert J. Ife, Thomas H. Brown, Colin A. Leach
  • Patent number: 4935431
    Abstract: Substituted 4-aminothienopyridine derivatives which are inhibitors of gastric acid secretion. A compound of the invention is 6-butyryl-7-(2-isopropylphenylamino)-thieno[3,2-b]pyridine.
    Type: Grant
    Filed: February 23, 1989
    Date of Patent: June 19, 1990
    Assignee: SmithKline Beckman Intercredit B.V.
    Inventors: Robert J. Ife, Thomas H. Brown, Colin A. Leach
  • Patent number: 4910305
    Abstract: This invention relates to chemical compounds which have selective thyromimetic activity. A compound of this invention is 3,5-dibromo-3'-[6-oxo-3(1H)-pyridazinylmethyl]-thyronine.
    Type: Grant
    Filed: March 16, 1988
    Date of Patent: March 20, 1990
    Assignee: Smith Kline & French Laboratories Limited
    Inventors: David Ellis, John C. Emmett, Anthony H. Underwood, Paul D. Leeson
  • Patent number: 4908475
    Abstract: New compounds which have potent V.sub.2 -vasopressin antagonistic activity are prepared by a 1,6-cyclization using peptide bond formation. The structures of the compounds are characterized by a Pas.sup.1,6 or Tas.sup.1,6 cyclized unit. Also a chiral synthesis of the optically pure Pas intermediates is described.
    Type: Grant
    Filed: May 9, 1988
    Date of Patent: March 13, 1990
    Assignee: SmithKline Beckman Corporation
    Inventors: James F. Callahan, William F. Huffman, Kenneth A. Newlander, Nelson C. F. Yim
  • Patent number: 4904664
    Abstract: The invention relates to pyridazinone derivatives which have inotropic, vasodilator and bronchodilator activity. The compounds of the invention are described by formula (I): ##STR1## wherein: R.sup.1 is hydrogen or methyl;R.sup.2 is hydrogen or methyl; and represent double or single bonds; and the benzene ring is para- or meta-substituted; and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: July 1, 1986
    Date of Patent: February 27, 1990
    Assignee: Smith Kline & French Laboratories Limited
    Inventors: Hunter D. Prain, Brian H. Warrington
  • Patent number: 4894372
    Abstract: This invention relates to 2-pyridine derivatives substituted in the 4-position with a dialkylamino- or piperidinyl- or pyrrolidinylalkyl group. The compounds have histamine H.sub.2 -antagonist activity.
    Type: Grant
    Filed: April 19, 1988
    Date of Patent: January 16, 1990
    Assignee: Smith Kline & French Laboratories Limited
    Inventors: David G. Cooper, George S. Sach
  • Patent number: 4888169
    Abstract: A vaccine for protecting canines against infection by Bordetella bronchiseptica is prepared by inactivating whole cells with glutaraldehyde.
    Type: Grant
    Filed: November 9, 1988
    Date of Patent: December 19, 1989
    Assignee: Norden Laboratories, Inc.
    Inventors: Albert L. Brown, Joseph C. Frantz, Richard H. Peetz
  • Patent number: 4885301
    Abstract: This invention relates to purinone derivatives which have bronchodilator, vasodilator and anti-allergic activities. A compound of the invention is 2-(2-propoxyphenyl)-6-purinone.
    Type: Grant
    Filed: January 27, 1988
    Date of Patent: December 5, 1989
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: William J. Coates
  • Patent number: 4882313
    Abstract: Carboxamide derivatives of glcopeptide antibiotics and their salts are useful for treating or preventing infection in an animal by gram-positive bacteria and also increase feed-utilization efficiency, promote growth in domestic animals and increase propionate production in lactating ruminants.
    Type: Grant
    Filed: July 31, 1987
    Date of Patent: November 21, 1989
    Assignee: SmithKline Beckman Corporation
    Inventor: Robert D. Sitrin
  • Patent number: 4876243
    Abstract: Vasopressin-like peptide whose structures have been modified by an alpha-methyl amino acid at the 4 or 7 position are set forth. These compounds have potent vasopressin antagonist activities.
    Type: Grant
    Filed: August 27, 1987
    Date of Patent: October 24, 1989
    Assignee: Smithkline Beckman Corporation
    Inventors: Garland R. Marshall, Michael L. Moore
  • Patent number: 4874792
    Abstract: This invention relates to alkanoic acid compounds having phenyl and thio substituents which are useful as leukotriene antagonists and pharmaceutical compositions containing such compounds. This invention also relates to treating diseases in which leukotrienes are a factor by administration of an effective amount of the above compounds or compositions.
    Type: Grant
    Filed: March 25, 1988
    Date of Patent: October 17, 1989
    Assignee: Smithkline Beckman Corporation
    Inventors: John G. Gleason, Ralph F. Hall, Thomas W. Ku, Carl D. Perchonock
  • Patent number: 4873328
    Abstract: A novel process for preparing alkoxyalkylidenehydrazinopyridazine derivatives which comprises reducing a novel alkoxytriphenylmethylazopyridazine derivative, removing the triphenylmethyl group and reacting with an aldehyde or ketone derivative.A specific compound produced by this process is 3-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-2-hydroxypropoxy]-6-isopropylid enehydrazinopyridazine.
    Type: Grant
    Filed: January 5, 1988
    Date of Patent: October 10, 1989
    Assignee: I.S.F. Societa Per Azioni
    Inventors: Carlo Farina, Mario Pinza, Alberto Cerri, Francesco Parravicini
  • Patent number: 4871771
    Abstract: A method for inhibiting the effects of LTB.sub.4 comprises administration of an effective amount of a compound represented by the following structural formula (I) ##STR1## wherein m is 1 or 2; n is 1, 2 or 3; p is 0, 1, or 2; R' is hydrogen or methyl; R is phenyl substituted with A, R.sub.1 and R.sub.2 wherein R.sub.1 and R.sub.2 are independently selected from either (1) (S).sub.a --(CH.sub.2).sub.b --(T).sub.c --B wherein a is 0 or 1; b is 5 to 12; c is 0 or 1; S and T are independently sulfur, oxygen, or CH.sub.2 with the proviso that S or T are not sulfur when p is 1 or 2; and B is C.sub.1-4 alkyl, ethynyl, trifluoromethyl, or phenyl optionally monosubstituted with Br, Cl, CF.sub.3, C.sub.1-4 alkoxy, C.sub.1-4 alkyl, methylthio, or trifluoromethylthio; or (2) hydrogen bromo, chloro, methyl, trifluoromethyl, methoxy or nitro; and A is selected from (2) as defined above or a pharmaceutically acceptable salt thereof. Such methods are useful in the treatment of diseases in which LTB.sub.4 is a factor.
    Type: Grant
    Filed: February 4, 1988
    Date of Patent: October 3, 1989
    Assignee: SmithKline Beckman Corporation
    Inventors: John G. Gleason, Sylvia T. Hoffstein, Charles M. Kinzig, Seymour Mong, Henry M. Sarau
  • Patent number: 4868313
    Abstract: The invention relates to 4-hydroxy pyrrolidone derivatives which help restore learning and memory difficulties associated with ageing. A compound of the invention is 2-(4-hydroxy-2-oxo-1-pyrrolidineacetamido)acetamide.
    Type: Grant
    Filed: January 23, 1989
    Date of Patent: September 19, 1989
    Assignee: I.S.F. Societa Per Azioni
    Inventors: Mario Pinza, Carlo Farina, Silvano Banfi, Ugo Pfeiffer
  • Patent number: 4865982
    Abstract: A DNA fragment from Streptomyces sp. which contains the XP55 gene expression unit.
    Type: Grant
    Filed: May 29, 1985
    Date of Patent: September 12, 1989
    Assignee: SmithKline Beckman Corporation
    Inventors: William V. Burnett, Jr., Thomas G. Eckhardt, Louis R. Fare
  • Patent number: 4866076
    Abstract: The invention provides a class of sulphonamide-containing tetrahydroisoquinolinyl compounds having thromboxane antagonist activity.
    Type: Grant
    Filed: July 21, 1988
    Date of Patent: September 12, 1989
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: Andrew D. Gribble
  • Patent number: 4863933
    Abstract: The disclosure relates to a class of 2-(pyridylalkylamino)-3-hydroxypyridines which are active as histamine H.sub.1 -antagonists.
    Type: Grant
    Filed: April 25, 1988
    Date of Patent: September 5, 1989
    Assignee: Smith Kline & French Laboratories Limited
    Inventors: David G. Cooper, Peter D. Miles, Rodney C. Young
  • Patent number: 4863936
    Abstract: Various substituted aminoalkylamino-2-pyridine derivatives are disclosed which are useful as histamine H.sub.1 -antagonists.
    Type: Grant
    Filed: October 21, 1986
    Date of Patent: September 5, 1989
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: George S. Sach
  • Patent number: 4861773
    Abstract: The invention relates to thiadiazinone derivatives that have utility as cardiac stimulants. A compound of the invention is 7-(1H-imidazol-1-yl)-9,9a-dihydroindeno[1,2-e][1,3,4]-thiadiazin-2(3H)-one .
    Type: Grant
    Filed: January 29, 1988
    Date of Patent: August 29, 1989
    Assignee: Smith Kline & French Laboratories Limited
    Inventors: William J. Coates, Lawrence I. Kruse
  • Patent number: 4859601
    Abstract: A DNA fragment from Streptomyces sp. which contains the Bgl protein (P49) promoter, the P1 promoter, for expressing heterologous genes.
    Type: Grant
    Filed: January 21, 1986
    Date of Patent: August 22, 1989
    Assignee: SmithKline Beckman Corporation
    Inventors: William V. Burnett, Jr., Thomas G. Eckhardt, Louis R. Fare